Bicycle Therapeutics to Participate in Upcoming Investor Conferences
Bicycle Therapeutics Reports Recent Business Progress and Second Quarter 2024 Financial Results
Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Bicycle Therapeutics Announces Four Abstracts Accepted for Presentation at the ESMO Congress 2024
Bicycle Therapeutics to Participate in Upcoming Investor Conferences
Bicycle Therapeutics Announces $555 Million Private Placement Equity Financing
Bicycle Therapeutics to Present Pharmacokinetic and Safety Evaluation of Lead BTC® Molecules in Phase 1/2 Trials at the 2024 ASCO Annual Meeting
Bicycle Therapeutics to raise $555M in one of the biggest PIPEs of the year: The company’s stock $BCYC was up 20% on Thursday morning after it announced the stock sale to healthcare investors, which included Deep Track Capital, EcoR1 Capital, Fairmount Capital, Forbion, Perceptive Advisors and RA Capital Management. Bicycle is set to present two posters at the upcoming ASCO meeting, which is the biggest cancer conference of the year. Abstracts are set to drop on Thursday evening. Bicycle declined to comment on whether the investors saw its ASCO data. — Lei Lei Wu
Bicycle Therapeutics Reports Recent Business Progress and First Quarter 2024 Financial Results
Bicycle Therapeutics Announces Two Abstracts Accepted for Presentation at the 2024 ASCO Annual Meeting